I just read this e-book, simply because, according to my friend this book is written by some of the ingenious individuals who foresaw and also profited even from the financial collapse. - Sunita
I heard people are using this e-book as a Self-help guide to investing. I recently finished studying it, and never have experimented with any of the strategies; however they all appear to make sense. - Rajiv
A fantastic guide overall. Quite different from almost all other value investing publications because it concentrates on finding unique scenarios that are best to invest in. - Alexis
This particular e-book really opened up my eyes to some fresh opportunities and possibilities that while investing I should be looking for. Once you have read this traditional value investing book you will learn a lot. - Kavita
I really like the writer of this book. It is simple, properly explained, amusing, relevant, and incredibly well planned. This particular e-book is really a holy bible for dealing with unique circumstances in the market. - Saurabh

History of Transgene Biotek Ltd.

V. COMPANY, MANAGEMENT and PROJECT

[1s] HISTORY, MAIN OBJECTS and PRESENT BUSINESS OF THE COMPANY

Transgene Biotek Limited incorporated as a Private Limited Company on 1st March, 1990, was subsequently converted into Public Limited on 28th November, 1990. The Comp. is engaged in the research & development & manufacture of various medical reagents both Bio-chemical and Immuno-Diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively

MAIN OBJECTS OF THE COMPANY

The main objects of Comp. as set out in the Memorandum of Association are as under;

1. To undertake, promote, assist or engage in all kinds of development work required in the field of Bio-Technology, to develop the entire spectrum of diagnosis by Enzymatic or Chemical methods useful in Bio-Chemical assays, ELISA and EIA systems & to develop the monitoring equipment for diagnostic systems.

2. To develop, manufacture, buy, sell, import, export, and deal in all types of vaccines, enzyme sensors for medical and environment applications DNA related products like immuno modulators Genetic Engineering in medical & health sectors, antigens of infection agents.

3. To set up laboratories develop, extract, import, export buy sell, deal in hire, the technology, process methods systems & to manufacture import, export buy sell, deal in hire the equipment & instruments, chemicals & enzymes which are capable of being used in the fields of Bio-Technology genetic engineering & diagnosis.

4. To carry on the business of manufacturing, producing, refining, developing, processing, or otherwise acquiring, buying, selling, importing, exporting, marketing and generally dealing in all kinds of drugs, medicines, pharmaceuticals, antibiotics, herbal, bacteriogical, and biological products, chemicals of all kinds, laboratory reagents & other preparations, compounds & articles, all kinds of products & by-products arising there from and in connection there with & all implements substances, apparatus, materials, & things incidental to or useful in connection with any of such business.

PRESENT BUSINESS

The Comp. has set up facilities for manufacture of Biochemical & Immuno diagnostic [ELISA, Latex agglutination and MIC s] reagents with present aggregate installed capacity of 168 lacs tests in Anrich Industrial Estate, Bollarum Medak dist. Andhra Pradesh.

FINANCIAL PERFORMANCE OF THE COMPANY

The Comp. commenced commercial production from 1st OCT, '93.

----------------------------------------------------------- 1993-94 ----------------------------------------------------------- Capacity utilisation [%s] 45.00 Production 94.68 Sales 252.91 Cost of production 177.31 PBIDT 75.78 Interest 41.91 Depreciation 13.44 PBT 20.42 PAT 20.42 Share Capital 340.00 Reserves 20.42 EPS [Rss] 0.60 Book Value 10.60 Break Even Point 36.68 ----------------------------------------------------------